e-Monitoring of Asthma Therapy to Improve Compliance in children.

The use of a Real-Time Medication Monitoring system (RTMM) for the improvement of adherence to inhalation corticosteroids in children with asthma.

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

NL-OMON

Registry ID

NL-OMON29009

Enrollment

220

Registered

2010-11-02

Start date

2011-01-01

Completion date

Unknown

Last updated

2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

asthma, adherence, inhaled corticosteroids, real time medication monitoring (RTMM), sms-reminder

Interventions

All children will receive a real time medication monitoring (RTMM) device that is connected to the pressurized metered dose inhaler (pMDI) with inhaled corticosteroids (ICS). Immediately after each in

Eligibility

Inclusion criteria

Inclusion criteria: 1. Children younger than 12 years old; 2. Diagnosed with asthma for at least 6 months; 3. ICS use for at least 3 months using a pMDI; 4. At least one parent or care giver has a mobile phone.

Exclusion criteria

Exclusion criteria: Refusal to participate in the study.

Design outcomes

Primary

Measure	Time frame
Percentage of inhalations taken within a 6 hour timeframe around the expected time of inhalation.	—

Secondary

Measure	Time frame
1. Asthma controll; 2. Asthma exacerbations; 3. Disease specific quality of life; 4. Acceptance of e-monitoring bij parents and children. Moreover, an economic evaluation will be performed adopting a societal perspective, including all relevant healthcare costs and productivity loss of the parents.	—

Contacts

Public ContactE.C. Vasbinder

Erasmus MC Afdeling apotheek Cluster 7 Postbus 2040

erwinvasbinder@gmail.com+31 (0)10 7033202

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)